Equities researchers at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of AMPE opened at $0.24 on Tuesday. The company has a market capitalization of $272,973.18, a price-to-earnings ratio of -0.02 and a beta of 2.14. Ampio Pharmaceuticals has a fifty-two week low of $0.14 and a fifty-two week high of $8.30. The business’s 50-day moving average is $0.93 and its 200-day moving average is $1.72.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last issued its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
About Ampio Pharmaceuticals
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Stories
- Five stocks we like better than Ampio Pharmaceuticals
- What Are Dividend Champions? How to Invest in the Champions
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What is a Dividend King?
- Generac Powers Ahead on the Electrification Mega-Trend
- Insider Selling Explained: Can it Inform Your Investing Choices?
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
